Cargando…

Chemiluminescence Biosensor for the Determination of Cardiac Troponin I (cTnI)

Cardiac vascular diseases, especially acute myocardial infarction (AMI), are one of the leading causes of death worldwide. Therefore cardio-specific biomarkers such as cardiac troponin I (cTnI) play an essential role in the field of diagnostics. In order to enable rapid and accurate measurement of c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tannenberg, Robert, Paul, Martin, Röder, Bettina, Gande, Santosh L., Sreeramulu, Sridhar, Saxena, Krishna, Richter, Christian, Schwalbe, Harald, Swart, Claudia, Weller, Michael G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136549/ https://www.ncbi.nlm.nih.gov/pubmed/37185530 http://dx.doi.org/10.3390/bios13040455

Ejemplares similares

Relationship between cardiac troponin I (cTnI) release during cardiac operations and myocardial cell death
por: Vazquez-Jimenez, JF, et al.
Publicado: (2000)

Severe Fetal Distress and Placental Damage Might Be Associated with High Troponin I (cTnI) Levels in Mothers
por: Turrini, Irene, et al.
Publicado: (2018)

High-sensitive cardiac troponin I (hs-cTnI) concentrations in newborns diagnosed with spinal muscular atrophy
por: Johannsen, Jessika, et al.
Publicado: (2023)

Cardiac troponin I but not cardiac troponin T adheres to polysulfone dialyser membranes in an in vitro haemodialysis model: explanation for lower serum cTnI concentrations following dialysis
por: Gaze, David C, et al.
Publicado: (2014)

Transitioning high sensitivity cardiac troponin I (hs-cTnI) into routine diagnostic use: More than just a sensitivity issue
por: Lee, Graham R, et al.
Publicado: (2016)

Differential analysis of transient increases of serum cTnI in response to handling in rats
por: Mikaelian, Igor, et al.
Publicado: (2013)

Biological Recognition-Based Electrochemical Aptasensor for Point-of-Care Detection of cTnI
por: Ma, Jianfeng, et al.
Publicado: (2023)

Theoretical analysis of immunochromatographic assay and consideration of its operating parameters for efficient designing of high-sensitivity cardiac troponin I (hs-cTnI) detection
por: Agarwal, Rahul, et al.
Publicado: (2023)

Correlations of Changes in Brain Natriuretic Peptide (BNP) and Cardiac Troponin I (cTnI) with Levels of C-Reactive Protein (CRP) and TNF-α in Pediatric Patients with Sepsis
por: Zhang, Yue, et al.
Publicado: (2019)

Prediction of Outcomes Through Cystatin C and cTnI in Elderly Type 2 Myocardial Infarction Patients
por: Ma, Jinling, et al.
Publicado: (2023)

Determination of Sarcocystis lamacanis microcysts in the cardiac muscle of alpacas (Vicugna pacos) and their correlation with troponin cTnI. A study performed in the high Andean region of southern Peru
por: Fernandez-F, Fernando, et al.
Publicado: (2022)

An ultrasensitive electrochemical sensing platform for the detection of cTnI based on aptamer recognition and signal amplification assisted by TdT
por: Lang, Mingjian, et al.
Publicado: (2020)

The TDs/aptamer cTnI biosensors based on HCR and Au/Ti(3)C(2)-MXene amplification for screening serious patient in COVID-19 pandemic
por: Mi, Xiaona, et al.
Publicado: (2021)

Puerarin pre-conditioning on the expression levels of CK-MB, cTnI and inflammatory factors in patients undergoing cardiac valve replacement
por: Zhou, Yuyang, et al.
Publicado: (2019)

Infantile restrictive cardiomyopathy: cTnI-R170G/W impair the interplay of sarcomeric proteins and the integrity of thin filaments
por: Cimiotti, Diana, et al.
Publicado: (2020)

The Diagnostic Value of Plasma miRNA-497, cTnI, FABP3 and GPBB in Pediatric Sepsis Complicated with Myocardial Injury
por: Huang, Chengjiao, et al.
Publicado: (2021)

Epigallocatechin gallate reverses cTnI‐low expression‐induced age‐related heart diastolic dysfunction through histone acetylation modification
por: Pan, Bo, et al.
Publicado: (2017)

Diagnostic Value of Echocardiography Combined with Serum h-FABP and cTnI in Myocardial Infarction and Its Evaluation Value in Left Ventricular Function
por: Miao, Yanling, et al.
Publicado: (2022)

Association of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study
por: Kruzan, Rachel M., et al.
Publicado: (2016)

Prediction of Perioperative Cardiac Events through Preoperative NT-pro-BNP and cTnI after Emergent Non-Cardiac Surgery in Elderly Patients
por: Ma, Jinling, et al.
Publicado: (2015)

Clinical use of submaximal treadmill exercise testing and assessments of cardiac biomarkers NT-proBNP and cTnI in dogs with presymptomatic mitral regurgitation
por: Wall, Leona, et al.
Publicado: (2018)

Joint Predictive Value of cTnI and NT-proBNP on Mortality in Patients with Coronavirus Disease 2019: A Retrospective Research in Wuhan, China
por: Weng, Haoyu, et al.
Publicado: (2021)

Retracted: Diagnostic Value of Echocardiography Combined with Serum h-FABP and cTnI in Myocardial Infarction and Its Evaluation Value in Left Ventricular Function
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Functional Divergence in Teleost Cardiac Troponin Paralogs Guides Variation in the Interaction of TnI Switch Region with TnC
por: Genge, Christine E., et al.
Publicado: (2016)

Effects of dexmedetomidine on H-FABP, CK-MB, cTnI levels, neurological function and near-term prognosis in patients undergoing heart valve replacement
por: Wang, Zhi, et al.
Publicado: (2017)

Kolaviron attenuated arsenic acid induced-cardiorenal dysfunction via regulation of ROS, C-reactive proteins (CRP), cardiac troponin I (CTnI) and BCL2
por: Oyagbemi, Ademola Adetokunbo, et al.
Publicado: (2017)

Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure
por: Gürgöze, Muhammed T., et al.
Publicado: (2022)

Skeletal Muscle Troponin I (TnI) in Animal Fat Tissues to Be Used as Biomarker for the Identification of Fat Adulteration
por: Park, Bong-Sup, et al.
Publicado: (2014)

Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease
por: Cao, Jiatian, et al.
Publicado: (2020)

NMR resonance assignment of a fibroblast growth factor 8 splicing isoform b
por: Hargittay, Bruno, et al.
Publicado: (2023)

Highly Sensitive Chemiluminescence-Based Lateral Flow Immunoassay for Cardiac Troponin I Detection in Human Serum
por: Han, Gyeo-Re, et al.
Publicado: (2020)

Significant reduction of peripheral blood interleukin-35 and CD4(+)EBI3(+) T cells, which are negatively correlated with an increase in the plasma IL-17 and cTnI level, in viral myocarditis patients
por: Ouyang, Han, et al.
Publicado: (2017)

An Aptamer-based Biosensor for Troponin I Detection in Diagnosis of Myocardial Infarction
por: Negahdary, M., et al.
Publicado: (2018)

Molecular tuning of farnesoid X receptor partial agonism
por: Merk, Daniel, et al.
Publicado: (2019)

Cocaine Detection by a Laser-Induced Immunofluorometric Biosensor
por: Paul, Martin, et al.
Publicado: (2021)

Applications of Nanomaterials in Electrogenerated Chemiluminescence Biosensors
por: Qi, Honglan, et al.
Publicado: (2009)

Evaluation of a newly developed chemiluminescence immunoassay for detecting cardiac troponin T
por: Wang, Jingkun, et al.
Publicado: (2017)

Long-Range Surface Plasmon-Polariton Waveguide Biosensors for Human Cardiac Troponin I Detection
por: Krupin, Oleksiy, et al.
Publicado: (2019)

Conformational switch in the ribosomal protein S1 guides unfolding of structured RNAs for translation initiation
por: Qureshi, Nusrat Shahin, et al.
Publicado: (2018)

Asia-Pacific consensus statement on the optimal use of high-sensitivity troponin assays in acute coronary syndromes diagnosis: focus on hs-TnI
por: Tan, Jack Wei Chieh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ia9sl854vu7jn7a9adg4s0o3gf